A target-dose finding study of clozapine in patients with schizophrenia

Annals of Clinical Psychiatry

Volumn 8, Issue 1, 1996, Pages 19-21

  Bennett, Jerry A ^a,b   Keck Jr , Paul E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Clozapine; Plasma concentrations; Schizophrenia; Therapeutic

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TITRIMETRY;

EID: 0029956247     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.3109/10401239609149086     Document Type: Article

References (13)

1. Kane JM, Honigfeld G, Singer J, Meltzer HY: Clozaril Study Group. Clozapine for the treatment resistant schizophrenic. Arch Gen Psychiatry 1988; 45:789-796
2. Miller DD, Fleming F, Holman TL, Perry PJ: Plasma clozapine concentrations as predictor of clinical response: A follow up study. J Clin Psychiatry 1994; 55(9; Suppl): 117-121
3. McGee M, Zwaag CV, McEvoy, Fields L, Piteria L: Clozapine plasma levels and therapeutic response. Psychopharmacol Bull 1994; 30:696
4. Perry PJ, Miller DD, Arndt SV, Cadoret RJ: Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 1991; 148:231-235
5. Hasegawa M, Gutierrez-Esteinou R, Way L, Meltzer HY: Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking. J Clin Psychopharmacol 1993; 13:383-390
6. Potkin SG, Bera R, Gulasekaram Costa J, Hayes S, Jin Y, Richmond G, Carrion D, Sitanggan K, Gerber B, et. al.: Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J Clin Psychiatry 1994; 55(S):133-36
7. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987:194-195
8. Choc MG, Lehr RG, Hsuan F: Multiple-dose pharmacokinetics of clozapine in patients. Pharmacol Res 1987; 4:405
9. Haring C, Meise V, Humpel C, Saria A, Fleischhacker WW, et al.: Dose-related plasma levels of clozapine: Influence of smoking behavior, sex, and age. Psychopharmacology 1989; 99:S38-S40
10. Pitscitelli Sc, Frazier JA, McKenna K, Albus KE, Grothe DR, Gordon CT, Rapoport JL: Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: Association with response. J Clin Psychiatry 1994; 55:9 (Suppl B): 94-97
11. Baldessarini RJ, Frankenburg FR: Clozapine, a novel antipsychotic. N Eng J Med 1991; 324:746-754
12. Fischer V, Voges B, Maurer G, Tynes RE: The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. J Pharmacol Exp Ther 1991; 260:1355-1359
13. Jann MW, Grimsley SR, Gray EC, Chang WH: Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 1993; 24(2):161-176